Dosage effects of orally administered bovine type I collagen on immune function in patients with systemic sclerosis
- 5 August 2004
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (8), 2713-2715
- https://doi.org/10.1002/art.20361
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Early expression of interferon gamma following oral antigen administration is associated with peripheral tolerance inductionMicrobes and Infection, 2003
- Increased transcriptional activities of transforming growth factor β receptors in scleroderma fibroblastsArthritis & Rheumatism, 2002
- Factors Involved in the Regulation of Type I Collagen Gene Expression: Implication in FibrosisExperimental Biology and Medicine, 2002
- Can we induce tolerance in rheumatoid arthritis?Current Rheumatology Reports, 2001
- Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: Association with increased expression of the type I collagen geneArthritis & Rheumatism, 2000
- Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapyThe Lancet, 1996
- Suppression of antigen‐induced arthritis in lewis rats by oral administration of type ii collagenArthritis & Rheumatism, 1995
- Transcriptional control of human diploid fibroblast collagen synthesis by γ-interferonBiochemical and Biophysical Research Communications, 1984
- Assessment of patient satisfaction in activities of daily living using a modified stanford health assessment questionnaireArthritis & Rheumatism, 1983
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980